CN104419662A - Building of atrial septal defect cell model and cell bank of atrial septal defect cell model by employing SV40LT and hTERT gene transfection - Google Patents

Abstract

The invention relates to building of an atrial septal defect cell model and a cell bank of the atrial septal defect cell model by employing SV40LT and hTERT gene transfection in the field of cardiovascular disease research. The building is mainly characterized by comprising the following steps: connecting a product obtained through digesting plasmid SV40LTag DNA and vector pcDNA3.1 (1) DNA by using BamHI enzyme with T4DNA to build an SV40LTag-pcDNA3.1 (1) recombinant; connecting the product obtained through double digesting plasmid pCIneo-hTERT and vector pLXSNneo by using EcoR I and Xho I with Ligation Mix to build a pLXSNneo-hTERT recombinant; transfecting histocyte with lipidosome after the two recombinants are amplified, purified and identified by competent cells; screening cells containing positive recombinants by G418, cloning and carrying out enlarging cultivation; and screening a cell of which the cell morphology, the growth curve, karyotype, nude mice tumor experiment result, transfection cell telomerase activity, an hTERT mRNA expression product, immumohistochemical staining, the cell generation cycle and the apoptosis rate accord with characteristics of a immortalized cell and are the same as or similar to those of a primary cell to be cryopreserved in liquid nitrogen as an in vitro research cell model for the atrial septal defect of a congenital heart disease, built by SV40LT and hTERT gene transfection; and a foundation is laid for in vitro long-term research of pathogenesis from the cellular level.

Description

SV40LT and hTERT gene transfection builds atrial septal defect cell model and cell bank thereof

Technical field

The present invention relates to SV40LT (simian virus 40 large T antigen gene) and hTERT (reverse transcriptase of telomere catalytic subunit) gene transfection (SV40LT and hTERT mediation) and build atrial septal defect cell model and cell bank thereof, be mainly used in cardiovascular diseases research field, the in vitro study for congenital heart disease atrial septal defect provides cell model and preserves its Scientific Research Resource.

Background technology

Congenital heart disease atrial septal defect is one of inborn defect that sickness rate is the highest, has become serious social concern.China newly sends out congenital heart disease 11.2 ten thousand-16.0 ten thousand example every year, will cause financial loss 10,900,000,000-156 hundred million; The treatment cost of congenital heart disease, every year up to 12,000,000,000 yuan, is caused serious psychological burden and soul pain to society and family, has had a strong impact on the quality of the people of China, become the heavy burden of social development and the serious hindrance of Sustainable development.

Research and the intervention of the inborn defects such as congenital heart disease have become Chinese government's behavior, and Party Central Committee's " decision " came into effect " inborn defect Intervening Project " from 2006; President of the People's Republic of China makes " on October 27th, 1994 the 30 No. three " announces the regulations standard that China implements (inborn defect) antenatal diagnosis from June 1 nineteen ninety-five; The National People's Congress has promulgated a series of regulation such as " People's Republic of China's law on health care of mother and baby ", " People's Republic of China's law on health care of mother and baby implementing method " in succession, facilitates inborn defect antenatal diagnosis, the carrying out of Prevention Intervention; Emphasize to strengthen inborn defect Intervention density in " 11th Five-Year Plan outline of national economy and social development ", improve the health of newborns; In " National Program for Medium-to Long-term Scientific and Technological Development (2006-2020) ", the research of inborn defect is classified as preferential theme.

Think that congenital heart disease atrial septal defect is the interactional results of complex relationship such as h and E factor at present, mainly comprise 1.. the environmental factors of fetation: poison as ill in first trimester or bacteriological infection especially rubella virus, next is Coxsackie virus, and the sickness rate of the congenital heart diseases in infants of its birth is higher.Other is as the pathology of amnion, fetus pressurized, First Trimester threatened abortion, maternal nutrition is bad, diabetes, phenylketonuria, hypercalcemia, radioactive rays and cytotoxic drug are in the application of First Trimester, and the excessive grade of maternal age all has the possibility making fetus generation congenital heart disease.2. inherited genetic factors: most congenital heart diseases is interacted by multiple gene and environmental factors formed.3. other factors: also have relation with area, sex.

In recent years, the research of the inborn defects such as congenital heart disease is mainly carried out to the investigation of epidemiology aspect for the relation of heredity, biology, physics, chemical factor and morbidity (rate).But, due to do not have can in vitro long-term cultivation, the immortality cell model that can be used for congenital heart disease Mechanism Study and cell bank thereof, just be difficult to study from cell levels the mechanism such as transgenation, genetic expression, changing function, physiological property, biology conduction that congenital heart disease atrial septal defect cell affects by physics, chemistry, biology, heredity etc. in vitro, thus seriously limit the further research of congenital heart disease atrial septal defect.

Foreign literature is reported, simian virus 40 (SV40) can make some human cell that immortalization occurs.The research such as Poulin DL, Kung AL and Sullivan CS shows, the importing of SV40T antigen gene can accelerate the growth velocity of transformant, after immortalized cells repeatedly goes down to posterity in vitro, still there is metastable multiplication characteristic and functional status, also can retain many phenotypic differentiations of its initiating cell simultaneously, may be used for the foundation of the cell model of transgenic animal model and some kind of human and animal, the characteristic of initiating cell can be studied accordingly by means of research transgenosis immortalized cells and animal model in vitro, thus study its pathogenesis.

But abroad studies have found that recently, the cell of SV40Tag transfection is along with the loss of DNA damage repair mechanism, the unstable of caryogram and a few cell neoplastic transformation.In addition; long-term in vitro is cultivated and is found that the cell of part transfection SV40Tag just extends the life-span; or only tided over senescence phase (MI phase), most cell finally can enter climacteric (M2 phase) and dead, and cell being not immortalized is described.Simultaneously SV40 virus has tumorigenicity, and with the generation of some tumour, develop relevant, it is restricted that the cell of therefore SV40Tag transfection also exists to a certain degree to some research.

Foreign study shows, imports exogenous hTERT and cell can be made to keep normal phenotype and differentiating characteristic.Utilized hTERT successfully to establish the immortalized cell line of some cell in recent years, substantially kept that chromosome stabilityX, differentiation are normal, contact inhibition, growth characteristics without relative " normally " such as tumorigenicity.May be used for the foundation of the cell model of some kind of human and animal, to the characteristic studying initiating cell by means of research transgenosis immortalized cells model, thus study its pathogenesis, have great importance.In stomatology field, Japanese scholars Kamata, Fujita and Fujii transfection hTERT establishes immortal human Gingival Fibroblasts, periodontal cell, pulp cells system and Dental Follicle Cells system, cell population doublings number reaches more than 150 times, cell all shows original biological characteristics, can express the associated protein of derived cell after inducing culture.The transfection hTERT such as Kitagawa establish people cementoblast system, and cell multiplication reaches more than 200 times, and cytodifferentiation mark such as alkaline phosphatase, type i collagen etc. are expressed stable.Because of the needs of research work, almost often kind of disease has respective cell model.As diabetes cell model, cancer cell model, transgenic cell model, climacteric syndrome cell model, endometrial cell model, epilepsy cell model, E-Cell models, alcoholic dementia cell model, cerebral edema cell model.Etc..

Separately have foreign study to show, when human tissue cell cultivates in vitro can within a short period of time dead and cannot go down to posterity, namely enter senescence phase (M1 phase) front will be dead.But simian virus 40 (SV40) can make some human cell that immortalization occurs; cell can be made to tide over M1 after date and to continue survival, Secondary Culture 20-30 generation; then cell can enter again climacteric (M2 phase); cell mortality increases and accompanies chromosome abnormalty; the cell of division reduces gradually, most cell death.And hTERT can maintain the stable of cell chromosome telomere, thus cell is tided over a crisis the phase (M2 phase), survival can be continued, going down to posterity reaches 100-300 generation more than.If so set up immortalized cell line with transfected with human in vitro tissue cell while of SV40 and hTERT, so SV40 can make cell tide over the M1 phase, and hTERT can make cell tide over the M2 phase, than being used alone, one of them clone set up is more stable, the life-span is longer.

But, so far there is not yet about being used in the external bibliographical information studying the pathogenetic immortality cell model of congenital heart disease atrial septal defect and cell bank thereof from cell levels with transfered cell while of simian virus 40 large T antigen gene (SV40LT) and reverse transcriptase of telomere catalytic subunit (hTERT) to set up immortal cell line and to build with this, also cannot carry out the research of relevant item.In order to address this problem, present inventors have proposed the present invention.

Summary of the invention

The object of the invention is to provide SV40LT and hTERT gene transfection (SV40LT and hTERT mediation) to build the method for atrial septal defect cell model and cell bank thereof, another object is atrial septal defect cell model for providing SV40LT and hTERT gene transfection to build from the pathogenesis of cell levels research congenital heart disease atrial septal defect in vitro and cell bank thereof.

The object of the present invention is achieved like this: connect the product through BamHI digested plasmid SV40LTag DNA and carrier pcDNA3.1 (-) DNA with T4DNA, builds SV40LTag-pcDNA3.1 (-) recon, and connect the product through EcoRI and Xho I double digestion plasmid pCIneo-hTERT and carrier pLXSNneo with Ligation Mix, build pLXSNneo-hTERT recon, two recons enter congenital heart disease atrial septal defect histocyte with liposome transfection after competent cell amplification purification and qualification, the cell clone enlarged culturing that contain positive recombinant is screened through G418, screening cellular form, growth curve, karyotype, nude mice tumorigenesis is tested, transfectional cell telomerase activation, hTERT mrna expression product, immunohistochemical staining, cell generation cycle and apoptosis rate meet immortalized cells characteristic and identical with primary cell or close person to mediate congenital heart disease atrial septal defect in vitro study cell model as SV40LT and hTERT frozen in liquid nitrogen, for its pathogenesis that studies for a long period of time in vitro from cell levels lays the foundation.

The present invention is with pcr amplification, agarose gel electrophoresis purification SV40LT and hTERT, import congenital heart disease atrial septal defect cell through genophore pcDNA3.1 (-) DNA and pLXSNneo with lipofection respectively and build its cell model, its histocyte digest with 0.01% collagenase II and need not be conventional tryptic digestion, digested or make cell suspension with the collagen only making to cause cytoadherence, the protein decreasing cell walls is digested and injure cell, makes the success ratio of cell cultures bring up to more than 95% by general about 85%; Select the defined medium containing 20mL/L foetal calf serum, 5 ~ 10nmol/L Regular Insulin, make cell can not grow too fast and affect the integration of hTERT gene, also can not make because lacking nutrition or Growth of Cells stimulating factor cell do not meet the requirements of converge rate, do not enter logarithmic phase before with regard to premature death, or logarithmic phase shortens; Clone recovery cultivation after frozen 1 month in-196 DEG C of liquid nitrogen of preparation, all can grow attached cell; When making clone Chromosome Identification, the consumption of colchicine and action time are conventional 5 ~ 10 times, and chromosome separation is increased mutually, are enough to counting and analyze; In addition, set up immortalized cell line with transfected with human in vitro tissue cell while of SV40LT and hTERT, SV40 can make cell tide over the M1 phase, and hTERT can make cell tide over the M2 phase, and than being used alone, one of them clone set up is more stable, the life-span is longer.

Accompanying drawing explanation

Fig. 1 is congenital heart disease atrial septal defect cell model (adherent growth) figure prepared by the present invention.

As Fig. 1, passage to the 135th generation, be cultured to the 7th day time, in logarithmic growth, circle, fusiformis, to be paved with bottle at the bottom of, its Growth of Cells converges rate and reaches more than 96%, and after this along with the increase of passage number, Growth of Cells is slack-off, thinning to be dredged.

Embodiment

1, the extraction of SV40LT and hTERT: (1) enzyme cuts SV40LT and hTERT: 1. enzyme cuts SV40LT: the SV40 freeze dried powder or the SV40 plasmid that contain large T antigen gene from commercially available purchase, be dissolved in appropriate H ₂in O or TE damping fluid, add 2uL10 × enzyme cutting buffering liquid, 18uL H ₂o and restriction enzyme BamH I (1-5U/ugDNA), 37 DEG C of incubation 1h, 75 DEG C of heating 15min, inactivator, adds 5uL electrophoresis sample loading buffer (also by adding 0.5mol/L EDTA) termination reaction in order to electrophoresis.2. enzyme cuts hTERT:hTERT between EcoRI and the SalI site of plasmid pClneo-hTERT, and pLXSNneo vector multiple cloning site (MCS) is containing EcoRI and XhoI restriction enzyme site.From commercially available purchase pCIneo-hTERT plasmid, be dissolved in appropriate ultra-clean H ₂in O or TE damping fluid, add 2uL10 × enzyme cutting buffering liquid and 18uL H ₂o, add restriction enzyme EcoR I and each 0.5ul of Xho I, 37 DEG C of incubation 1h, 75 DEG C of heating 15min, inactivator, adding 5uL electrophoresis sample loading buffer (also by adding 0.5mol/L EDTA) termination reaction, routinely after PCR method amplification hTERT, collecting amplified material in order to electrophoresis.(2) SV40LT and hTERT electrophoresis: 1. SV40LT (SV40DNA) electrophoresis: power taking swimming level agarose is made into 10% sepharose with electrophoretic buffer, pour on the gel casting platform sealed, plug sample comb, from glue platform removing envelope band after gelling is solid, extract comb, put into the electrophoresis chamber being added with enough electrophoretic buffers, damping fluid exceeds gel surface and is about 1mm, DNA sample is prepared with 10 appropriate × sample loading buffer, then with pipettor, sample is added in sample well, and do suitable DNA molecular amount standard control thing simultaneously, connect electrode, DNA anode is moved, when under the voltage of 1-10V/cm gel, electrophoresis is to the distance of enough isolation of DNA fragments, powered-down.2. hTERT electrophoresis: power taking swimming level agarose is made into 10% sepharose with electrophoretic buffer, pour on the gel casting platform sealed, plug sample comb, from glue platform removing envelope band after gelling is solid, extract comb, put into the electrophoresis chamber being added with enough electrophoretic buffers, damping fluid exceeds gel surface and is about 1mm, prepare hTERT enzyme with 10 appropriate × sample loading buffer and cut sample, then with pipettor, sample is added in sample well, and do suitable standard control thing simultaneously, connect electrode, hTERT anode is moved, under the voltage of 1-10V/cm (80V) gel, electrophoresis is to (30min) during the distance of enough separation hTERT fragments, powered-down.(3) SV40LT and hTERT purifying and recovery: 1. SV40LT purifying and recovery: isolate about 2600bp SV40 large T antigen DNA from agarose: (use long wave ultraviolet light source to prevent DNA damage) and load in dialysis tubing by cutting containing the gel-tape of target DNA fragments under 300-360nm long wave ultraviolet light source, 2ml electrophoretic buffer is added in dialysis tubing, make it submergence gel, and emptying steam bubble, dialysis tubing level is put into electrophoresis chamber (length direction is parallel with electrophoresis), add appropriate amount of buffer solution by dialysis tubing submergence (about 6-7mm), switch on power, 150 volts of electricity are washed, observe under ultraviolet lamp and treat that DNA all shifts out gel, change direction of an electric field and continue energising 1 minute, from dialysis tubing, sucking-off damping fluid is in 1-5ml Eppendorf pipe, add 1.5 times of volume propyl carbinols, EB is removed in mixing extracting, on desk centrifuge 2 minutes the most at a high speed, suck upper strata butanol solution, repetition secondary like this, equal-volume phenol chloroform (2) extracting 2 times is added in the solution of lower floor DNA, supernatant liquor is transferred in another Eppendorf pipe and adds 1/10 times of volume 3M NaAc, 2 times of volume precooling dehydrated alcohols, spend the night in 20 DEG C, 12000g, at 4 DEG C centrifugal 10 minutes, obtain DNA precipitation, abandon supernatant, dry ethanol is abandoned after adding 70% washing with alcohol 2 times, add 50 μ l TE dissolving DNAs.In addition, also target DNA fragment is separated, is purified by available low melting-point agarose gel method, DNA filter membrane inserted sheet method etc. from gel.2. hTERT purifying and recovery: be separated hTERT band from agarose: under long wave ultraviolet light source, the gel-tape containing target hTERT fragment is cut and load in dialysis tubing, 2ml electrophoretic buffer is added in dialysis tubing, make it submergence gel, and emptying steam bubble, dialysis tubing level is put into electrophoresis chamber (length direction is parallel with electrophoresis), add appropriate amount of buffer solution by dialysis tubing submergence (about 6-7mm), switch on power, 150 volts of electricity are washed, observe under ultraviolet lamp and treat that hTERT all shifts out gel, change direction of an electric field and continue energising 1 minute, from dialysis tubing, sucking-off damping fluid is in 1-5ml Eppendorf pipe, add 1.5 times of volume propyl carbinols, EB is removed in mixing extracting, on desk centrifuge 2 minutes the most at a high speed, suck upper strata butanol solution, repetition secondary like this, equal-volume phenol chloroform (2) extracting 2 times is added in the solution of lower floor hTERT, supernatant proceeds in another Eppendorf pipe and adds 1/10 times of volume 3M NaAc, 2 times of volume precooling dehydrated alcohols, spend the night in 20 DEG C, 12000g, at 4 DEG C centrifugal 10 minutes, obtain hTERT precipitation, abandon supernatant, dry ethanol is abandoned after adding 70% washing with alcohol 2 times, add 50 μ l TE and dissolve hTERT.In addition, also object hTERT fragment is separated, is purified by available low melting-point agarose gel method, hTERT filter membrane inserted sheet method etc. from gel.

2, SV40LT with hTERT builds recon with carrier pcDNA3.1 and pLXSNneo respectively: the structure of (1) SV40LT/pcDNA3.1 recon: get the above-mentioned DNA composition of 9 μ l (0.1-5 μ g), 10 μ l2 × be connected damping fluid, 1 μ l10mmol/LATP, T4DNA ligase enzyme (20 ~ 500 sticky end unit) or e. coli dna ligase, pcDNA3.1 empty carrier mix, 15 DEG C of incubation 24h, are built into SV40LT/pcDNA3.1 recon.(2) structure of pLXSNneo-hTERT recon: get the hTERT composition (0.1-5 μ g) of the above-mentioned purifying of 9 μ l, 1 μ l10mmol/L ATP, 10ul Ligation Mix or e. coli dna ligase, the mixing of 2ul pLXSNneo empty carrier, 15 DEG C of incubation 24h, build pLXSNneo-hTERT recon.

3, the purifying of recon, amplification, qualification: the amplification of (1) SV40LT/pcDNA3.1 recon, Isolation and ldentification: the 1. preparation of E. coli competent: its basic skills is ice-cold CaCl ₂or the process such as multiple divalent positively charged ion bacterium, making it to enter competence is transformed, and uses CaCl ₂prepare fresh or freezing competent escherichia coli cell, be usually used in preparation in quantity competence bacterium, this law is applicable to most of coli strain, operating process is summarized as follows: cultivate picking single bacterium colony (as bacillus coli DH 5 2) the fresh plate of 16 ~ 20h from 37 DEG C, or 16 ~ 20h overnight culture that 1ml is fresh, forward one to containing in 1L or the 500ml flask of 100mlLB substratum, about 2 ~ 3h (rotary shaker 200 ~ 300r/min) is cultivated in 37 DEG C of violent joltings, OD600 value ≈ 0.4 is measured every 20 ~ 30min, aseptically bacterium is transferred to one, in ice-cold 50ml polypropylene centrifuge tube, after placing 10 ~ 20min on ice, in 4 DEG C with SorvallGS2 rotary head (or the rotary head matched with its centrifuge tube) with the centrifugal 10min of 4000r/min, to reclaim cell, nutrient solution reciprocal, pipe is inverted 1min to flow to end to make the trace nutrient solution of final residual, with the ice-cold 0.1mMCaCl of 10ml ₂resuspended every part of precipitation, be put on ice, in 4 DEG C with SorvallGS3 rotary head (or its corresponding rotary head) with the centrifugal 10min of 4000r/min, to reclaim cell, pour out nutrient solution, pipe is inverted 1min to flow to end to make the trace nutrient solution of final residual, the 0.1M CaCl of every 50ml initial incubation thing 2ml ice precooling ₂resuspended every part is sunk calmly, now, rapidly cell can be distributed into aliquot, freezing in liquid nitrogen,-70 DEG C of storages are for subsequent use, from every kind of competent cell suspension, getting 200 μ l with the sterile pipette tip of cooling transfers in aseptic Eppendorf tube, often pipe adds DNA or ligation mixture (volume≤10 μ l, DNA≤50ng), rotate gently to mix content, 30min is placed in ice, centrifuge tube is put into pre-heating on the test-tube stand in the circulator bath of 40 DEG C, place 90s ~ 2min, do not shake test tube, fast pipe is transferred in ice bath, cell is made to cool 1 ~ 2min, every centrifuge tube adds 800 μ lSOC substratum, with water-bath, substratum is warmed to 37 DEG C, then pipe is transferred on 37 DEG C of shaking tables, incubation 45min makes bacteria resuscitation, and antibiotic-resistance marker's gene of expression plasmid coding, the competent cell that proper volume (each 90mm flat board can reach 200 μ l) has transformed is transferred to containing on 200mmol/LMgSO4 and corresponding antibiotic SOB substratum, flat board is placed in room temperature to be absorbed to liquid, be inverted plate, in 37 DEG C of cultivations, bacterium colony can be there is after 12 ~ 16h.2. the screening of recon, amplification and extraction: select single colony inoculation in the aseptic LB substratum of 5mL or rich medium (as super broth or TB super broth substratum) with sterile toothpick or disinfection inoculation pin, after overnight incubation, join 500mL again containing in the 2L flask of LB substratum (containing suitable microbiotic), then be cultured to state of saturation (OD in 37 DEG C ₆₀₀≈ 4, for improving output, the flask of the comparatively large and band traverse baffle of surface-area should be adopted to increase venting quality as far as possible, jolting speed should be greater than 400r/min), in 4 DEG C, the centrifugal 10min of 6000g, by the resuspended precipitation of 4mL GTL solution, and transfer to (bacterial precipitation can be preserved at-20 DEG C or-70 DEG C of indefinitely) in the high speed centrifugation pipe of a volume>=20mL, add the GTE solution containing 25mg/mL N,O-Diacetylmuramidase that 1mL newly joins, resuspended precipitation, 10min is placed in room temperature, add 10mL and newly join NaOH/SDS solution, and mixing is until liquid becomes homogeneous gently, limpid and thickness, in placing 10min on ice, add 7.5mL acetic acid solution, stir until viscosity declines and forms large precipitation gently with suction pipe, in placing 10min on ice, in 4 DEG C, the centrifugal 10min of 20000g, supernatant is poured into gently in another clean centrifuge tube, if there is visible drift can by several layers of filtered through gauze, add the Virahol of 0.6 times of volume, put upside down mixing, room temperature places 5 ~ 10min, in room temperature, the centrifugal 10min of 1500g, add the washing precipitation gently of 2mL70% ethanol, then of short duration centrifugal fast, suck ethanol, and vacuum-drying (precipitation can be preserved for a long time at 4 DEG C).3. the qualification of recon: the above-mentioned DNA (containing SV40T/pcDNA3.1) extracted from competence intestinal bacteria, the same method restriction enzyme BamH I carries out enzyme and cuts, 10g/L agarose gel electrophoresis is identified, obtain 2 bands that size is about 2600bp and 5600bp, the former meets the size of SV40T fragment in GenBank.(2) purifying of pLXSNneo-hTERT recon, amplification, qualification: the 1. preparation of E. coli competent: its basic skills is ice-cold CaCl ₂or the process such as multiple divalent positively charged ion bacterium, making it to enter competence is transformed, and uses CaCl ₂prepare fresh or freezing competent escherichia coli cell, be usually used in preparation in quantity competence bacterium, this law is applicable to most of coli strain, operating process is summarized as follows: cultivate picking single bacterium colony (as bacillus coli DH 5 2) the fresh plate of 16 ~ 20h from 37 DEG C, or 16 ~ 20h overnight culture that 1ml is fresh, forward one to containing in lL or the 500ml flask of 100mlLB substratum, about 2 ~ 3h (rotary shaker 200 ~ 300r/min) is cultivated in 37 DEG C of violent joltings, OD600 value ≈ 0.4 is measured every 20 ~ 30min, aseptically bacterium is transferred to one, in ice-cold 50ml polypropylene centrifuge tube, 10 ~ 20min is placed on ice, in 4 DEG C with SorvallGS2 rotary head (or the rotary head matched with its centrifuge tube) with the centrifugal 10min of 4000r/min, to reclaim cell, nutrient solution reciprocal, pipe is inverted 1min to flow to end to make the trace nutrient solution of final residual, with the ice-cold 0.1mMCaCl of 10ml ₂resuspended every part of precipitation, be put on ice, in 4 DEG C with SorvallGS3 rotary head (or its corresponding rotary head) with the centrifugal 10min of 4000r/min, to reclaim cell, pour out nutrient solution, pipe is inverted 1min to flow to end to make the trace nutrient solution of final residual, the 0.1M CaCl of every 50ml initial incubation thing 2ml ice precooling ₂resuspended every part is sunk calmly, and now, rapidly cell can be distributed into aliquot, freezing in liquid nitrogen ,-70 DEG C of storages are for subsequent use.2. with competence intestinal bacteria purification and amplification pLXSNneo-hTERT recon: get 200 μ l respectively with the sterile pipette tip of cooling from often kind of competent cell suspension and transfer in aseptic Eppendorf tube, DNA or ligation mixture (volume≤10 μ l is added in every pipe, DNA≤50ng), rotate gently to mix content, 30min is placed in ice, centrifuge tube is put into pre-heating on the test-tube stand in the circulator bath of 40 DEG C, place 90s ~ 2min, do not shake test tube, fast pipe is transferred in ice bath, cell is made to cool 1 ~ 2min, every centrifuge tube adds 800 μ l SOC substratum, with water-bath, substratum is warmed to 37 DEG C, then pipe is transferred on 37 DEG C of shaking tables, incubation 45min makes bacteria resuscitation, and antibiotic-resistance marker's gene of expression plasmid coding, the competent cell that proper volume (every 90mm flat board can reach 200 μ l) has transformed is transferred to containing on 200mmol/LMgSO4 and corresponding antibiotic SOB substratum, flat board is placed in room temperature to be absorbed to liquid, be inverted plate, in 37 DEG C of cultivations, bacterium colony can be there is after 12 ~ 16h.3. screen, increase recon: select single colony inoculation in the aseptic LB substratum of 5mL or rich medium (as super broth or TB super broth substratum) with sterile toothpick or disinfection inoculation pin, after overnight incubation, join 500mL again containing in the 2L flask of LB substratum (containing suitable microbiotic), then be cultured to state of saturation (OD in 37 DEG C ₆₀₀≈ 4, for improving output, the flask of the comparatively large and band traverse baffle of surface-area should be adopted to increase venting quality as far as possible, jolting speed should be greater than 400r/min), in 4 DEG C, the centrifugal 10min of 6000g, by the resuspended precipitation of 4nL GTL solution, and transfer to (bacterial precipitation can be preserved at-20 DEG C or-70 DEG C of indefinitely) in the high speed centrifugation pipe of a volume>=20mL, add the GTE solution containing 25mg/mL N,O-Diacetylmuramidase that 1mL newly joins, resuspended precipitation, 10min is placed in room temperature, add 10mL and newly join NaOH/SDS solution, and mixing is until liquid becomes homogeneous gently, limpid and thickness, in placing 10min on ice, add 7.5mL acetic acid solution, stir until viscosity declines and forms large precipitation gently with suction pipe, in placing 10min on ice, in 4 DEG C, the centrifugal 10min of 20000g, supernatant is poured into gently in another clean centrifuge tube, if there is visible drift can by several layers of filtered through gauze, add the Virahol of 0.6 times of volume, put upside down mixing, room temperature places 5 ~ 10min, in room temperature, the centrifugal 10min of 1500g, add the washing precipitation gently of 2mL70% ethanol, then of short duration centrifugal fast, suck ethanol, and vacuum-drying (precipitation can be preserved for a long time at 4 DEG C).4. the qualification of recombinant plasmid and amplification: the single bacterium colony on picking plate, be inoculated in 3ml containing in 100ug/ml penbritin LB substratum, 37 DEG C, cultivate in 250r/min shaking table, culture is collected after 14h, 4 DEG C, the centrifugal 5min of 10000r/min, extract and purification of Recombinant plasmid in a small amount by test kit specification sheets; With EcoRI and HindIII double digestion recombinant plasmid reaction system: each 0.5ul of restriction enzyme, 10 × buffer2ul, recombinant plasmid 10ul, adding water complements to 20ul, 37 DEG C of enzymes cut 1h.Digestion products carries out 0.8% agarose electrophoresis under 80V voltage conditions, time 30min, and gel imaging system is taken pictures; Measure the sequence of recombinant plasmid routinely; Recombinant plasmid is cut through enzyme, after qualification accurately of checking order, by the microbionation containing this plasmid in LB nutrient solution, amplification cultivation, carries out heavy dose of plasmid extraction purifying by heavy dose of plasmid extraction test kit specification sheets, and ultraviolet spectrophotometer is for subsequent use after measuring plasmid concentration and purity.

4, recon SV40LT/pcDNA3.1 and pLXSNneo-hTERT imports the screening of congenital heart disease atrial septal defect cell and positive colony thereof: the collection of (1) congenital heart disease atrial septal defect cell and cultivation: be extracted in aseptic technique and do other and test or other check unnecessary, the amniotic fluid slough tissue cell of congenital heart disease patients with atrial septal defect discarded afterwards, be about 1 × 10 with final concentration of cells ⁵/ mL is for subsequent use, the cell got above-mentioned cell in single dispersion or become single dispersion is after treatment inoculated in containing 5 ~ 10nmol/L Regular Insulin, in the RPMI1640 liquid of 20% foetal calf serum or be inoculated in containing 20% foetal calf serum, in the low sugar DMEM cell culture medium of 5 ~ 10nmol/L Regular Insulin, be placed in 37 DEG C, in volume fraction 5%CO2 incubator, cell attachment is cultivated about 3 ~ 4 days, cellular form is fusiformis, little circular cell is less than 10%, the rate of converging of attached cell reaches 75% ~ 85%, be in when just entering logarithmic phase, namely consider to collect culturing cell, first blot the nutrient solution in clean culturing bottle, add collagenase II liquid or the pancreatin (can cover at the bottom of whole bottle with Digestive system and be as the criterion) of 1-2ml0.01%, leave standstill 2-10min (under microscope dynamic monitoring), suck collagenase II liquid, add low sugar DMEM or RPMI1640 nutrient solution, culture in glassware liquid is drawn with suction pipe, repeatedly blow and beat bottle parietal cell, make into cell suspension, centrifugation, remove supernatant liquor, after cell precipitation cleans 2 times with above-mentioned nutrient solution, make suspension, import as recon.(2) recon SV40LT/pcDNA3.1 and pLXSNneo-hTERT imports congenital heart disease atrial septal defect cell: method 1: select lipofection, gets 2 × 10 of method Isolated cells ⁵individual cell is inoculated in 35mm culture dish, at 37 DEG C of CO ₂24 ~ 36h cultivated by incubator, make Hemapoiesis individual layer, cellular form be fusiformis, there is not yet or be rarely seenly less than 10% little circular cell, the rate of converging of attached cell reaches 55% ~ 65%, is in when just entering logarithmic phase, can transfection SV40LT/pcDNA3.1 and pLXSNneo-hTERT.In 1.5ml Eppendorf tube, prepare following solutions: pipe A, recon SV40LT/pcDNA3.1 is dissolved in 50 μ l serum-free mediums; Pipe B, is dissolved in 50 μ l serum-free mediums by recon pLXSNneo-hTERT; Pipe C, be dissolved in 80 μ l serum-free mediums by 20 μ l liposome Lipofectamine, pipe A, pipe B and pipe C mix, and put 45min under room temperature.After sucking above-mentioned cell culture fluid, with serum-free medium washed cell 2 times, 1ml serum-free medium is added in Lipofectamine-SV40LT/pcDNA3.1 and Lipofectamine-pLXSNneo-hTERT mixture, mix gently, drop to again in Tissue Culture Dish, then 1ml serum-free medium is added, at CO ₂10h cultivated by incubator, sucking-off transfection liquid, and add 4ml complete culture solution and continue to cultivate 16h, discard nutrient solution, changing concentration is 400mg ° of L ^-1g418 nutrient solution continue to cultivate, within 8 ~ 10 days, select individual cells colony to carry out subclone afterwards, strengthen G418 concentration after enlarged culturing again to 800mg ° of L ^-1, in the G418 environment of high density, amplification of going down to posterity can be carried out by the clone of stable growth.Method 2: draw 1/10-1/40 cell suspension, being mixed with final concentration is 1 × 10 ⁵/ mL cell suspension, be inoculated in culturing bottle, select low sugar DMEM or RPMI1640 substratum, wherein containing 20mL/L foetal calf serum, 10nmol/L Regular Insulin, after cultivating 48h, make Hemapoiesis individual layer, cellular form is fusiformis, there is not yet or rarely seenly be less than 10% little circular cell, attached cell converges rate and reaches 55% ~ 65%, be in when will enter or just enter logarithmic phase, adopt the method for liposome transfection, by recon pLXSNneo-hTERT and SV40LT/pcDNA3.1 transfection in congenital heart disease atrial septal defect cell, with the liquid medium-selection 1w containing 700mg/L G418, change G418 concentration into 300mg/L, to occurring positive colony, transfer them to new culturing bottle to expand, Secondary Culture, method 3: above-mentioned cell suspension is made into 5 × 10 with low sugar DMEM or RPMIl640 nutrient solution ⁸the cell suspension inoculation of/L final concentration is in the culture plate in 24 holes, until cell grow to about 90% merge time for transfection, by recon SV40LT/pcDNA3.1 and pLXSNneo-hTERT respectively containing 0.2 μ g, adjusting volume with DMEM or RPMI1640 is respectively 50 μ l, and room temperature places 5min, liposome 15 μ l, adjusting volume with DMEM is 50 μ l, then room temperature places 5min, mentioned reagent is mixed gently, then room temperature places 20min, cell DMEM in 24 orifice plates is washed 3 times, after every hole adds nutrient solution 100 μ l, add Lipofectamine-SV40LT/pcDNA3.1 and Lipofectamine-pLXSNneo-hTERT mixture more gently after cell surface paving is even, 6h is placed in 37 DEG C of 5%CO2 incubators, use 0.01g/L collagenase by cell dissociation subsequently, proceed in 6 orifice plates, add perfect medium, adding G418 microbiotic next day makes final concentration be 500mg/L, until there is monoclonal cell to grow.Have monoclonal cell colony to grow after about 10d, picking is also placed in continuation cultivation in 24 orifice plates, maintains and stabilize with the G418 of 300mg/L the amplification cultivation that goes down to posterity.Setting up with this can the immortalization congenital heart disease atrial septal defect cell model of Secondary Culture repeatedly in vitro.

5, the amplification of going down to posterity of SV40LT/pcDNA3.1 and pLXSNneo-hTERT transfection congenital heart disease atrial septal defect cell model: collect the above-mentioned positive monoclonal cell colony importing SV40LT/pcDNA3.1 and pLXSNneo-hTERT through lipofection, be made into about 1 × 10 with low sugar DMEM or RPMI1640 substratum ⁵the cell suspension of/mL, is inoculated in several bottles of 20 ~ 50cm ²in culturing bottle, add 5mL containing 20mL/L foetal calf serum, the low sugar DMEM of 10nmol/L Regular Insulin or RPMI1640 substratum, grow to cell attachment, converge rate and reach 80 ~ 85%, collecting cell when being in the early stage of logarithmic phase, again by above-mentioned steps Secondary Culture, inoculation of repeatedly going down to posterity like this, cultivate, record algebraically and observation of cell growth characteristic, as Fig. 1, passage is to the 135th generation, when being cultured to the 7th day, in logarithmic growth, circular, fusiformis, at the bottom of being paved with bottle, its Growth of Cells converges rate and reaches more than 96%, after this along with the increase of passage number, Growth of Cells is slack-off, thinning thin.Wherein logarithmic growth refers to high cell growth speed, and the increase of cell quantity and incubation time are multiplication relation, when usually cultivating by kind of a cell routinely, cultivates the individual cells that just can find growth for 1 ~ 2 day under the microscope; Visible cell colony when 4 ~ 5 days, at the bottom of adherent growth cell bedding culturing bottle 1/3, at the bottom of visible adherent growth cell bedding culturing bottle more than 2/3 when cultivating 7 ~ 13 days, even cell overlap, interspace hardly (converge rate and reach 95 ~ 100%), cell light, without particle, without catabiosis such as harsh feelings, also can judge according to the relation of cell counting and incubation time; Dead cell is few, and cause death and floating cell are less than 10% [differentiate dead cell and viable cell by trypan blue staining, because normal viable cell, after birth structural integrity, can repel, and trypan blue can not be entered in born of the same parents weekly; And the cell of loss of activity, the permeability of after birth increases, blueness can be dyed by trypan blue, can be judged as that cell is dead, method draws weekly a certain amount of suspension culture, mixes rearmounted room temperature 5 ~ 10 minutes, then make cell sheet with Trypan Blue agent, count 1000 total cellular score under the microscope, calculate the per-cent of painted dead cell and non-staining viable cell].

6, the qualification of immortalization congenital heart disease atrial septal defect cell model biological characteristics: use the cell model (clone) that SV40LT/peDNA3.1 and pLXSNneo-hTERT sets up, the key issue of qualification has: is that this cell of requirement has lasting multiplication capacity; Two is that its form of requirement, basic physiological function etc. remain unchanged.Whether 1. observation of cell form: every day, whether observation of cell was in typical epithelial cell sample adherent growth under inverted light microscope is fusiformis or the growth of little circular.This clone goes down to posterity the cellular form of amplification cultivation and Normal human fibroblast's form no significant difference; 2. observation of cell growth curve: get the good transfectional cell of growth, adopts 0.25 trypsin solution digestion, makes cell suspension, through counting, get 1.4 × 10 respectively ⁴cell is inoculated in 30 containing 15FBS low sugar DMEM-culture medium culturing bottle.Get 2 bottles of cells every day to count, computation of mean values, Continuous Observation, until cell quantity obviously declines, is cultivated after 3 days and was changed liquid every 2 days to the cell of no count, adopts same method to observe the growing state of transfectional cell in hepato ZYME-SFM serum free medium.Result take incubation time as transverse axis, and cell quantity is the longitudinal axis (logarithm), be depicted in semi-logarithmic scale to make after curve the growth curve of this cell, immortalized cell line is formed in typical " S " feature or " arched roof "; 3. karyomit(e) is checked: by analyzing karyotype, if karyotype is diploid " 46; XX " or " 46; XY ", or be same as the primary cell of the present invention's collection, then illustrate that vicious transformation (whether occur abnormal DNA colony in available flow cytometry analysis clone simultaneously, if do not had, illustrate that knurl feature does not appear in clone yet) does not occur this clone.Chromosome karyotype analysis method is: reach 85-95% (its medium and small circular cell accounts for 10%) at cell density, to be in the culture of logarithmic phase in by 5mL nutrient solution the 250ug/ml colchicine 100ul adding preheating, mix rearmounted 37 DEG C of incubators 4 hours, blot nutrient solution, add the 2-3mL EDTA-trysinization liquid of preheating, 37 DEG C act on 5 minutes, stop digestion, wash lower attached cell, through centrifugal, hypotonic, fixing, film-making, G aobvious band post analysis karyotype; 4. soft agarose growth test: by cell with 5 × 10 ⁴it is in 35mm soft agar plate that/ml is inoculated in diameter, after observing three weeks, does not find Clone formation, illustrates that the immortalized cells of this experiment can not form clone in soft agar, meets immortalization feature; 5. nude mice tumorigenesis test: by immortalized cells with 3 × 10 ⁷inoculation nude mice dorsal sc, after 2 months, 4 nude mices are showed no tumour and are formed, and prove that this cell is non-malign cells; 6. transfectional cell hTERT mrna expression product measures: do pcr amplification rear electrophoresis by test kit, detect hTERT mRNA band.As with Immunohistochemical detection, in the nucleus of hTERT transfection, the visible a large amount of brown particle of dyeing, shows that hTERT has been integrated in cell; 7. transfectional cell telomerase activation: collecting cell system, illustrates by test kit and prepares lysate, does pcr amplification and electrophoretic analysis, with 302nm UV-light observations, visible in Telomerase positive band.8. Flow cytometry: the cell proportion detecting synthesis in the 19th continuous cell line, division, if its multiplication capacity obviously strengthens than not building the normal cell being, explanation is the result that hTERT and SV40LT integrates, expresses; In addition with Flow cytometry cell generation cycle and apoptosis rate, the Proliferating antigen Ki67 comparatively front nothing of the transfection obviously change of this clone, the comparatively front obvious reduction of transfection of Transfected cells apoptosis rate; 9. the large T gene test of transfectional cell SV40: as with Immunohistochemical detection, in the nucleus of SV40 transfection, the visible a large amount of brown particle of dyeing, shows that SV40T antigen has been integrated in cell; Also the expression of T antigen in cell can be detected by RT-PCR method, the wherein primer of T antigen: upstream primer (A4239) 5 '-GTT ATG ATT ATA ACT GTT ATG-3 ', downstream primer (S4496) 5 '-GAA ATG CCA TCT AGT GAT-3 '; Amplified production length is 268bp, and amplification condition is 94 DEG C, 5min, that is: and (94 DEG C, 1min; 55 DEG C, 1min ,-0.5 DEG C/circulation; 72 DEG C, 1min) × 30, (94 DEG C, 30S; 40 DEG C, 30S, 72 DEG C, 30S) × 15, amplification system is 50 μ l:[Mg ²⁺] 2mmol/L, dNTPs200 μm ol/L, primer concentration 0.4 μm of ol/L, Taq1U, template 5 μ l; Experimental group with the 19th generation cell cDNA for template (with reference to commercially available cDNA first chain synthetic agent box carry out cDNA first chain synthesis, product-20 DEG C preservation); Negative control establishes two, template is done respectively with the cDNA of sterilized water, primary cell, positive control is that template (extracts SV40DNA with reference to SDS-proteinase-K pathway with SV40DNA, because SV40 virus is without coating, do not use SDS rupture of membranes, get 5 μ l and carry out 1.5% agarose gel electrophoresis detection, all the other-20 DEG C save backup); 10. SV40 large T gene mRNA expression product measures: T antigen mRNA RT-PCR product checks order: the amplified production getting 100 μ l systems, test kit (Takara is reclaimed with gel, Japan) reclaim product, get 2 μ l DNA solutions and dilute 100 times, survey concentration, remaining DNA and each 10 μ l of upstream and downstream primer checks order, and meets the sequence of SV40 large T gene mRNA expression product.

So cell model of the present invention is the epithelial cell sample adherent growth of (1) cell in fusiformis or little circular under inverted light microscope; (2) growth curve of cell is as taken incubation time as transverse axis, and cell quantity is the longitudinal axis, is that " S " feature or " arched roof " are formed in hepato ZYME-SFM serum free medium; (3) karyotype is diploid " 46, XX " or " 46, XY ", or is same as the primary cell of the present invention's collection; (4) cell can not grow (forming clone) in soft agar; (5) cell is non-malign cells, nude mice tumorigenesis negative; (6) incorporate SV40LT and hTERT gene in the DNA of cell simultaneously, express the mRNA product of SV40LT and hTERT gene simultaneously; (7) passage to the 135th generation, be cultured to the 7th day time, in logarithmic growth, circle, fusiformis, to be paved with bottle at the bottom of, its Growth of Cells converges rate and reaches more than 96%, and after this along with the increase of passage number, Growth of Cells is slack-off, thinning to be dredged; (8) can repeatedly freeze-thaw, more than Secondary Culture 135 generation; (9) the external pathomechanism from cell levels research congenital heart disease atrial septal defect is used for as cell model; (10) genetic resources of the congenital heart disease atrial septal defect that SV40LT and hTERT integrates simultaneously is preserved on recyclability ground.

7, SV40LT with hTERT mediates congenital heart disease atrial septal defect cell model and cell bank thereof: screening also enlarged culturing meets immortalized cells characteristic and the cell identical or close with primary cell after above-mentioned qualification, get the attached cell that growth conditions is good, be in the different generations of logarithmic phase, through digestion, stop and centrifugation (1200r/min, 6min), with the frozen storing liquid 0.5 ~ 1ml re-suspended cell containing methyl-sulphoxide, cell density is 5 × 10 ⁵individual/ml, adds cryopreservation tube, packing, mark, through 4 DEG C, and 0.5h;-20 DEG C, 2h;-70 DEG C, spend the night, enter-196 DEG C of liquid nitrogen cryopreservations.Build the stable immortalization congenital heart disease atrial septal defect cell model of biological characteristics and cell bank thereof in this way, with concentrated preservation genetic resources, for other researchs provide scientific research material, and as the cell model of congenital heart disease atrial septal defect pathogenesis in vitro study, to accelerate the new way expanding the research of congenital heart disease atrial septal defect, congenital heart disease atrial septal defect cell study in vitro for a long period of time by physics from cell levels, chemistry, biological, heredity waits the transgenation of impact, genetic expression, changing function, physiological property, the mechanism such as biological conduction.

8, cell model is applied: congenital heart disease atrial septal defect cell model is as scientific research cell: make congenital heart disease atrial septal defect cell model be in the artificial nuisance with different content or concentration manufactured as physics (as X-ray), chemistry is (as formaldehyde, gasoline, plumbous, mercury), biological (as rubella virus, cytomegalovirus, simplexvirus) condition under cultivate, then the viable cell of the different cycles of external Long Term Passages is got, the apoptotic cell of succeeding generations, nutrient solution containing the meta-bolites produced in Secondary Culture from different perspectives and level, comparative study congenital heart disease atrial septal defect cell model, normal control cells model is to the difference of the tolerance of nuisance, nuisance causes the mechanism of congenital heart disease atrial septal defect.Such as apply ordinary method as the gene of the screening differences such as gene chip, miRNA chip, comparative genomic hybridization hybrid chip (CGH), differential methylation hybridization hybrid chip (DMH) and SNPs and polymorphism, methylation level, the gene rate of rotation in the technology for detection gene place such as in situ hybridization (FISH), Northern blot, Real-timePCR, CHIP, EMSA research cell model is used to express, locate and regulation and control, utilize the meta-bolites of protein metabolism process and key in enzyme reaction, metabonomic technology identification of cell model Long Term Passages, application two-dimensional electrophoresis, MALDI-TOF Mass Spectrometric Identification, the protein function of the technical study such as yeast two-hybrid and co-immunoprecipitation cell model in Long Term Passages and the interaction between protein, dynamic from viable cell culturing process, the congenital heart disease that studies for a long period of time atrial septal defect cell is to the tolerance of bad environmental factor and adaptability, such as: 1. common in environment toxicant benzopyrene causes the research of congenital heart disease atrial septal defect: make congenital heart disease atrial septal defect cell model and compared with control cells contain 0.1 respectively, 1.0, 5.0, 10.0, cultivate in the nutrient solution of 20.0pmol/L benzopyrene, detect cultivation 2 weeks, 4 weeks, 6 weeks, 8 weeks, the apoptosis that can be used as cytotoxicity index of the different incubation time such as 16 weeks, downright bad, dikaryocyte rate and the micronuclear rates that can be used as genetoxic index, caryoplasm bridge rate, core bud rate, namely the micronucleus number in 10000 dikaryocytes is counted under an optical microscope, caryoplasm bridge number and core bud number, necrosis and apoptosis cell count in 500 viable cell, dikaryocyte number, and detection cell survival rate, namely tetrazolium-based colorimetric assay (mtt assay) is applied, after sucking original fluid, 96 orifice plates add the serum-free medium of the 5mg/mlMTT of 20%, continue to cultivate 4h, supernatant liquor in hole is abandoned in careful suction, every hole adds 150 μ L methyl-sulphoxides, vibration 10min, purple crystal thing is fully dissolved, and this microplate reader measures the absorbance in each hole with 490nm, calculates cell survival rate.Other normal experiment methods can also detect containing toxic substance and not containing the transgenation, proteomics, emiocytosis function, chromosome aberration, cell survival rate (life-span) etc. of respectively organizing cell in toxic substance, congenital heart disease atrial septal defect cell model and normal cell of different incubation time, with, study bad environmental factor mechanism of action to congenital heart disease atrial septal defect cell dynamic from cell levels from viable cell culturing process.2. replace toxicant benzopyrene with certain sex pheromone and do same research, can from viable cell culturing process from cell levels dynamically, the congenital heart disease that studies for a long period of time atrial septal defect cell is to the tolerance of biotic factor and adaptability and mechanism of action.3. by the medicine being made into concentration gradient be made into the sex pheromone of concentration gradient or poisonous chemical substance and cell model co-cultivation, detect cell cultivation process life-span, transgenation, various molecule changes etc., can from viable cell culturing process from cell levels dynamically, the medicine that studies for a long period of time is to the result for the treatment of of congenital heart disease atrial septal defect and intervention effect.4. the method for same available congenital heart disease atrial septal defect cell model research gene therapy, substitutes some and directly does experiment with human body.5. the genetic resources of congenital heart disease atrial septal defect person is preserved with the form of cell model.

Claims (7)

1. the method for the structure atrial septal defect cell model of SV40LT and the hTERT gene transfection for medical field and cell bank thereof, its principal character is with the product of T4DNA connection through BamHI digested plasmid SV40LTag DNA and carrier pcDNA3.1 (-) DNA, builds SV40LT-pcDNA3.1 (-) recon, and connect the product through EcoR I and Xho I double digestion plasmid pCIneo-hTERT and carrier pLXSNneo with Ligation Mix, build pLXSNneo-hTERT recon, two recons import congenital heart disease atrial septal defect histocyte with liposome transfection after competent cell amplification purification and qualification, the cell clone enlarged culturing that contain positive recombinant is screened through G418, screening cellular form, growth curve, karyotype, nude mice tumorigenesis is tested, transfectional cell telomerase activation, hTERT mrna expression product, immunohistochemical staining, cell generation cycle and apoptosis rate meet immortalized cells characteristic and the congenital heart disease atrial septal defect in vitro study cell model that builds as SV40LT and hTERT gene transfection of identical with primary cell or close person is frozen in liquid nitrogen, for laying the foundation from cell levels (substituting human body or animal straightway testing) its pathogenesis that studies for a long period of time in vitro.

2. SV40LT and hTERT gene transfection according to claim 1 builds the method for atrial septal defect cell model and cell bank thereof, it is characterized in that indication cell model be (1) cell be under inverted light microscope the epithelial cell sample adherent growth of fusiformis or little circular; (2) growth curve of cell is as taken incubation time as transverse axis, and cell quantity is the longitudinal axis, is that " S " feature or " arched roof " are formed in hepato ZYME-SFM serum free medium; (3) karyotype is diploid " 46, XX " or " 46, XY ", or is same as the primary cell of the present invention's collection; (4) cell can not grow (forming clone) in soft agar; (5) cell is non-malign cells, nude mice tumorigenesis negative; (6) incorporate SV40LT and hTERT gene in the DNA of cell simultaneously, express the mRNA product of SV40LT and hTERT gene simultaneously; (7) passage to the 135th generation, be cultured to the 7th day time, in logarithmic growth, circle, fusiformis, to be paved with bottle at the bottom of, its Growth of Cells converges rate and reaches more than 96%, and after this along with the increase of passage number, Growth of Cells is slack-off, thinning to be dredged; (8) can repeatedly freeze-thaw, more than Secondary Culture 135 generation; (9) the external pathomechanism from cell levels research congenital heart disease atrial septal defect is used for as cell model; (10) genetic resources of the congenital heart disease atrial septal defect that SV40LT and hTERT integrates simultaneously is preserved on recyclability ground.

3. SV40LT and hTERT gene transfection according to claim 1 builds the method for atrial septal defect cell model and cell bank thereof, it is characterized in that taking from gathers because other experiments are required and congenital heart disease atrial septal defect infant amniotic fluid cast-off cells that are unnecessary after other experiments, that discard build it.

4. SV40LT and hTERT gene transfection according to claim 1 builds the method for atrial septal defect cell model and cell bank thereof, it is characterized in that nutrient solution used is the RPMI1640 containing 20% foetal calf serum, 5 ~ 10nmol/L Regular Insulin or the low sugar DMEM nutrient solution containing 20mL/L foetal calf serum, 5 ~ 10nmol/L Regular Insulin.

5. SV40LT and hTERT gene transfection according to claim 1 builds the method for atrial septal defect cell model and cell bank thereof, it is characterized in that being used as Secondary Culture imports recon congenital heart disease atrial septal defect histocyte in order to lipofection, in primary amplification cultivation, its collect index be cell attachment cultivate about 3 ~ 4 days, cellular form is fusiformis, little circular cell less than 10%, the rate of converging of attached cell reaches 75% ~ 85%, is in collecting cell when just entering logarithmic phase; Import the congenital heart disease atrial septal defect histocyte that goes down to posterity of recon as lipofection, the index of its choose opportunities is cellular form be fusiformis, there is not yet or be rarely seenly less than 10% little circular cell, the rate of converging of attached cell reaches 55% ~ 65%, is in culturing cell when entering or just entered logarithmic phase; The index that continuous cell line is collected be select cell attachment growth converge that rate reaches 80 ~ 85%, collecting cell when being in the early stage of logarithmic phase; The cell harvesting index of chromosome karyotype analysis is that cell density reaches 85-95%, little circular cell accounts for more than 10%, is in the cell of logarithmic phase.

6. SV40LT and hTERT gene transfection according to claim 1 builds the method for atrial septal defect cell model and cell bank thereof, it is characterized in that the histocyte digesting adherent growth with 0.01% collagenase II, when making chromosome karyotype analysis, add 250ug/ml colchicine 100ul in every 5mL nutrient solution, mix rearmounted 37 DEG C of incubators 4 hours.

7. SV40LT and hTERT gene transfection according to claim 1 builds the method for atrial septal defect cell model and cell bank thereof, it is characterized in that the structure of cell bank comprises (1) screening and after qualification, meets immortalized cells characteristic and the congenital heart disease atrial septal defect cell that builds of SV40LT and the hTERT gene transfection identical or close with primary cell; (2) go down to posterity, enlarged culturing, get the attached cell that growth conditions is good, be in the different generations of logarithmic phase; (3) through digestion, termination, centrifugal (1200r/min, 6min) step harvested cell; (4) preparing density with the frozen storing liquid containing methyl-sulphoxide is 5 × 10 ⁵the cell suspension of individual/ml; (5) according to 4 DEG C, 0.5h;-20 DEG C, 2h;-70 DEG C, spend the night; Enter the program freeze-stored cell of-196 DEG C of liquid nitrogen; (6) the long-term congenital heart disease atrial septal defect cell model preserving SV40LT and hTERT gene transfection structure in recyclability ground, for making genetic resources and scientific research material.